Pharmaceutical Preparations · CIK 1816736
Disc Medicine develops novel treatments for blood disorders by modifying red blood cell formation and iron balance
Comparable business profile · signals at a glance
In the 90 days to Mar 2, 2026: 7 sold $25.4M.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sell | 4,392 | $65.52 | $288K |
| Mar 2, 2026 | Savage William JacobChief Medical Officer | Sell | 2,986 | $66.41 | $198K |
| Feb 25, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 353 | $69.06 | $24K |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 3,684 | $65.89 | $243K |
| Feb 18, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 3,397 | $65.01 | $221K |
| Feb 17, 2026 | Quisel John DChief Executive Officer | Sell | 13,264 | $62.86 | $834K |
| Feb 17, 2026 | Stephenson PamelaChief Commercial Officer | Sell | 5,531 | $62.86 | $348K |
| Feb 17, 2026 | Franchi Jean M.Chief Financial Officer | Sell | 4,075 | $62.86 | $256K |
| Feb 17, 2026 | Savage William JacobChief Medical Officer | Sell | 3,256 | $62.86 | $205K |
| Feb 17, 2026 | Yu Jonathan Yen-WenChief Operating Officer | Sell | 3,231 | $62.86 | $203K |
| Feb 17, 2026 | Khara RahulChief Legal Officer | Sell | 2,853 | $62.86 | $179K |
| Jan 20, 2026 | Khara RahulChief Legal Officer | Sell | 1,000 | $69.74 | $70K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 4,993 | $78.62 | $393K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 1,157 | $79.27 | $92K |
| Jan 2, 2026 | Khara RahulChief Legal Officer | Sell | 350 | $77.67 | $27K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 393 | $91.47 | $36K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 213 | $91.47 | $19K |
| Dec 17, 2025 | Bitterman KevinDirector | Sell | 148 | $91.47 | $14K |
| Dec 16, 2025 | Bitterman KevinDirector | Sell | 35,898 | $91.24 | $3.3M |
| Dec 16, 2025 | Bitterman KevinDirector | Sell | 18,666 | $91.24 | $1.7M |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.